US Patent Number

9,718,799

Publication Date

8-1-2017

Abstract

Isoflavonoids or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof for the treatment of prostate cancer or for the treatment or inhibition of prostate cancer metastasis in a patient in need thereof are disclosed.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

15/149,940

Filing Date

05/09/2016

Included in

Oncology Commons

Share

COinS